Health Highlights: March 28, 2022

Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more
Second COVID-19 vaccine boosters to be offered to Americans over 50. Optional second boosters of the Pfizer or Moderna vaccines could be authorized by the U.S. Food and Drug Administration as early as this week. But debate rages over the timing and effectiveness of such a move. Read more
Owners can play big role in dogs' problem behaviors. Nearly 1 in 3 pet dogs suffer from ADHD-like repetitive behaviors, and researchers now suspect that an animal's home life could be the cause. Read more
Hospitalization extremely rare for the vaccinated or those with prior COVID infection. A study of more than 100,000 American patients found their odds of winding up in the hospital following a 'breakthrough' infection was practically nil. Read more
Related Posts
Severity Reduced With Mpox Reinfection, Postvaccination Infection
MONDAY, Sept. 11, 2023 (HealthDay News) -- The clinical features and outcomes of...
AHA News: Tu hogar –y su localización– podrían afectar tu salud
MARTES, 1 de agosto de 2023 (American Heart Association News) -- Se dice que el...
¿Estoy deprimido? Esté atento a los síntomas más comunes
VIERNES, 12 de mayo de 2023 (HealthDay News) -- ¿Piensa que quizá se esté...
Report IDs Characteristics of Adult ED Visits for Nonfatal Opioid Overdose
FRIDAY, June 2, 2023 (HealthDay News) -- A report published online May 23 in the...